RxSight Inc (NASDAQ: RXST) is a medical device company focused on the treatment of cataracts through a proprietary adjustable intraocular lens system. The company makes money by selling its Light Adjustable Lens (LAL) and the associated Light Delivery Device (LDD) used to customize vision after cataract surgery. The LAL system allows post-surgical adjustment of a patient's vision correction using ultraviolet light, differentiating it from fixed intraocular lenses implanted by competitors. RxSight sells its products to ophthalmologists and cataract surgery centers, primarily in the United States. The filing was made on 2026-02-25 covering the fiscal year ended in that period. Due to limited financial detail in the available filing excerpts, specific revenue figures, segment breakdowns, customer counts, and named competitors cannot be confirmed from this source and are omitted accordingly.
Source: SEC 10-K, filed 2026-02-25
Industry: Ophthalmic Goods Peers: Bioventus Inc CERUS CORP Sanara Medtech Inc OraSure Technologies Inc Pulmonx Corp VolitionRX Ltd SmileDirectClub, Inc. TELA Bio Inc Utah Medical Products Inc
Loading...